anti-PD1 treatmentimmune checkpoint therapyTNG260pembrolizumab
…t CoREST inhibition by TNG260 sensitizes STK11-mutant tumors to anti-PD1 treatment. TNG260, in combination with pembrolizumab, is being evaluated …
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 3,601–3,660 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
immunosuppressant medications1immunosuppression regimens1immunosuppression screening1immunosuppression therapy1immunosuppressive drug therapy1immunosuppressive or biologic therapy1immunosuppressives1immunotherapeutic agents1immunotherapeutic treatments1immunotherapy-based1immunotherapy-refractory1immunotherapy-treated1implantable PNS therapy1implantable cardiac defibrillator deactivation1improved nutrition1in situ immunotherapy1in vivo gene delivery1incisional negative pressure wound therapy1indefinite anticoagulation therapy1indefinite treatment1individual psychological therapy1individualised management1individualised treatment approaches1individualized treatment1induction chemotherapy regimen1induction immunotherapy1indwelling pleural catheters1infant open-heart surgery1inferior treatments1infraclavicular approach1infraclavicular brachial plexus block1inguinal fist compression1inhaled beta-agonists1inhaled bronchodilators1inhaled corticosteroid (ICS) maintenance therapy1inhaled medications1inhaled therapies1inhaled therapy prescriptions1injectable therapy1innovative therapies1innovative treatments1inotropic support1inpatient neurorehabilitation1inpatient treatment1insulin administration1insulin infusion1insulin use1insulin-requiring1integrase strand transfer inhibitor-based regimens1intense immunosuppression1intensified therapy1intensive care1intensive electrolyte correction1intensive neurocritical monitoring1intercostal nerve cryoablation1intermittent fasting1intermittent preventive treatment1internal radiotherapy1internet-based treatment1interpersonal psychotherapy1
Articles mentioning treatments
7,227 articles · page 231 of 603lymphodepleting chemotherapyAGX-148oral head and neck squamous cell carcinomamelanomathyroid cancersolid tumorsProvidence Institutional Review BoardClinicalTrials.gov
…ard and experimental therapies. Patients undergo tumor harvest, lymphodepleting chemotherapy, adoptive transfer of AGX-148 and high-dose IL-2 for one week, …
immunotherapyNanO 2Glioblastoma MultiformeNanO2PaclitaxelTNBCTriple-negative breast cancerDOD GrantBALB/c mice
… experiments, we tested the effect of NanO2 in combination with immunotherapy (IT), chemotherapy (CTX, paclitaxel) or both IT and CTX. BALB/c…
Triplet therapyanthracycline chemotherapyFTY720Flt3LTNBCDoxil D1NCT05029999
…s) as well as by blocking lymphocyte egress with FTY720.Results Triplet therapy significantly delayed tumor progression and extended median sur…
immunotherapyBreast cancerQUICKARRAYS, Inc
…y mapped the TME to identify features potentially predictive of immunotherapy response. FFPE (Formalin-Fixed Paraffin-Embedded) tissue slide …
T-FUSUniversity of Virginiacancerbreast cancerBCNIH DP5OD031846αCD40
…t of CD4+ T cells following rechallenge (figure 2O).Conclusions T-FUS+αCD40 represents a novel paradigm for immunotherapy of BC-capab…
anti-PD-1 therapyPD-1 therapyMD Anderson Cancer CenterKAN-001non-small cell lung cancerNSCLCCRCHUMCanadian Council
… evaluated in the MCA205 murine tumor model in combination with anti-PD-1 therapy. Comparative arms included treatment with FMT from ICI-non-resp…
immune checkpoint blockadeHER2-targeted therapyLeica BiosystemsIndica Labsgastric and gastroesophageal junction (GEJ) adenocarcinomaHER2-amplified colorectal cancerHER2-low breast cancerHER2-positive breast cancer
…, suggesting possible synergy between HER2-targeted therapy and immune checkpoint blockade.In HER2-amplified colorectal cancer, PD-L1 expression and immun…
immunotherapychemotherapyMassachusetts General HospitalMGH Histopathology Research CoreTNBCImmunomedics/GileadSacituzumab govitecantriple-negative breast cancerhuman breast cancer
…ody drug conjugates to activate anti-tumor immunity and enhance immunotherapy response.Acknowledgements We gratefully acknowledge Immunomedic…
Adoptive CTL therapyimmunotherapymelanoma-specificExtramammary Paget’s disease (EMPD)IL-2EMPDmelanomaRadiother Oncolsolid tumorsEBV-related cancers+1 more
…es in solid tumors, yet limited data exist in the EMPD context. Adoptive CTL therapy, which involves the ex vivo expansion and activation of autolog…
ImmunotherapyAzaAzacytidineAMLAcute Myeloid Leukemia
… AML has remained largely unchanged over the last four decades. Immunotherapy is a promising therapy in many cancers including AML. T cell ex…
immunotherapyEwing SarcomaChildren’s Oncology GroupIL1RAP
…on of the immune environment in ES may reveal the blockades for immunotherapy efforts and potential new pathways to be exploited in the futur…